It's World Pancreatic Cancer Day and we're demanding attention for a disease that gives very few early warnings โ
Know the signs, listen to your body and speak to your GP about changes that persist.
Help someone else do the same ๐
https://t.co/U1qtm666cX
@worldpcc
Every week matters for people with pancreatic cancer.
New treatments are showing promise, but many wait nearly two years to be listed on the PBS.
Share your story with your MP and ask them to support faster access to new treatments: https://t.co/r9AIWsUtZB
#EveryWeekMatters
Pankind has been named a finalist for NGO of the Year in the Health Industry Hub Awards 2026.
Together, weโre making pancreatic cancer impossible to ignore.
See you at the Awards on 5 November! ๐
#PancreaticCancerAwareness#NGOoftheYear
A major pancreatic cancer breakthrough has happened in the US: the FDA has approved daraxonrasib after Phase 3 results nearly doubled median overall survival. Now Pankind is pushing for a clear, timely pathway for Australian access https://t.co/Nr56W4tBLQ
#pankind#daraxonrasib
๐ Pankind volunteer Milton Kirkwood is a finalist in the Westfield Local Heroes awards!
He now has the chance to secure a $20,000 grant for Pankind to support programs for people affected by pancreatic cancer.
Help Milton and Pankind by voting here https://t.co/JXimuG5bVP
Knowing you may have an inherited risk of pancreatic cancer is one thing. Knowing what to do next is another. Pankind has practical tools that help people understand their risk, navigate next steps & speak with their medical team. https://t.co/rQhY03ImVz #pancreaticcancer
Missed out on a City2Surf spot? Charity Superstar spots are still available with Team Pankind ๐
Commit to raise $1,000 and help fund pancreatic cancer research, treatment improvements and vital support. Run for something bigger ๐ https://t.co/EzttrRtVZg
#City2Surf2026#Pankind
๐ Pankind has been nominated for NGO (Non-Government Organisation) of the Year in the Health Industry Hub Awards 2026.
Help us shine a brighter spotlight on pancreatic cancer and elevate our advocacy efforts.
Vote here ๐https://t.co/ZkGIYDEAz3
#HealthIndustryHubAwards2026
Driving Impact: Pankind's Strategy 2026โ2030. Pancreatic cancer survival rates have barely improved in 15 years. We are dedicated to new treatment programs, early detection initiatives, advocacy & care & support services
Read the strategy: https://t.co/fo1CGbtHTz
After years of limited progress, the positive RASolute 302 trial results at #ASCO shows that change is happening right now. This is the start of better treatments and a fair fight for patients.
Hope is never wasted๐
Cheers, chills, and a standing ovation when RASolute 302 showed unprecedented survival on daraxonrasib for patients with progressive pancreatic cancer
Seldom do you sense youโre witnessing a historic moment in cancer care but this feels like ras targeting has arrived
#ASCO26
Federal Budget wins for pancreatic cancer:
๐ฃ@OmicoAustraliaโs PrOSPeCT program funded through 2028
๐ฃRenewed investment in the National One Stop Shop to speed up trial access
Faster trial access can mean more time. Pankind will keep pushing for hope. Read CEO statement on LI
A new pancreatic cancer blood test has launched in Australia. Encouraging early signals, but itโs best viewed as an additional option while research continues. MRI + EUS remain gold standard for high-risk surveillance.
Read more: https://t.co/iYxzF4hT3k
Today is World Pancreatic Cancer Day ๐ฃ
The time to act is now! Know the signs, act early and help spread awareness.
@worldpcc
๐ Share this message
๐ Start a conversation
๐ https://t.co/GpNbFv4381
#WPCD#HelloPancreas#EarlyDetectionMatters
After losing both his father and uncle to pancreatic cancer, Dr Will McGahan chose to expand his impact. Weโre proud to award Dr McGahan The Marianne Allan Pancreatic Cancer Research Grant as part of Pankindโs 2025 Grant Program.
๐https://t.co/uWhRI3VXWL
November is Pancreatic Cancer Awareness Month!
Pancreatic cancer often stays silent until itโs too late, knowing the signs can save lives.
Donโt ignore these subtle symptoms, early action matters.
Share to help spread awareness๐
@worldpancreatic
๐ https://t.co/1FNK9seJAQ
Remember September 2025!
Together, weโve raised $2,677,185 to advance pancreatic cancer research and improve outcomes for people affected by this disease. Shortly, we will be announcing the recipients of our 2025 Grants, made possible through movements like Remember September.
In a recent feature by Natasha Robinson for The Australian, the APRISE Study was brought into focus: the first national screening program for people with an increased familial or genetic risk of pancreatic cancer.
๐ https://t.co/neXtAgbX7X
When pancreatic cancer treatment options were limited, Dee began a Phase 1 KRAS G12D clinical trial at The Kinghorn Cancer Centre.
Watch Dee's story of hope amidst Australia's toughest cancer.
Full article available here๐ https://t.co/5PDJ5oHl5t
Can a colorectal cancer drug help treat Australiaโs deadliest common cancer?
NP137 is now being tested in pancreatic cancer labs. It targets both cancer cells and their environment, a key factor in this disease.
Pankind CEO spoke to @7NewsMelbourne about the urgency of this.
Pankind are Telstra Best of Business Award Finalists and itโs all thanks to you ๐
Weโre proud to share that we have been named a Finalist in the 2025 Telstra Best of Business Awards, recognised in the Community Building category ๐
#TelstraBestofBusinessAwards